TrialCardiovascular diabetology2020

Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.

Naoto Katakami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.